Alle Fotos(1)
Wichtige Dokumente
BPQ24
BioPORTER® QuikEase™ Protein Delivery Kit
for intracellular delivery
Synonym(e):
BioPORTER Kit, Protein Delivery Kit
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Größe auswählen
1 KIT
€ 861,00
€ 861,00
Check Cart for Availability
Alle Fotos(1)
Größe auswählen
Ansicht ändern
1 KIT
€ 861,00
About This Item
UNSPSC-Code:
12352202
NACRES:
NA.26
€ 861,00
Check Cart for Availability
Empfohlene Produkte
Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich
Verwandte Kategorien
Allgemeine Beschreibung
Contains 24 individual tubes of BioPORTER reagent
Anwendung
BioPORTER® QuikEase™ Protein Delivery Kit has been used to deliver active granzyme B tagged with FITC into mouse neuroblastoma cell lines. Protein concentrations used for delivery were 6μg/ml which when stained for FITC-GrB yielded a 90% uptake rate. [1]
BioPORTER® QuikEase™ Protein Delivery Kit has been used:
- for the delivery of single-chain antibody variable fragment (scFv) into HeLa cells[2]
- for the transduction of QBI-293 cells with human Tau protein[3]
- for the delivery of human granzyme B (GrB) in human cervical cancer cells[4]
- for the delivery of epidermal fatty acid-binding protein (E-FABP) into nerve growth factor-differentiated PC12 cells (NGFDPC12)[5]
The BioPORTER® QuikEase™ Protein Delivery Kit is the latest innovation in macromolecule delivery technology. It is a unique lipid-based formulation that allows for the intracellular delivery of proteins, peptides, and bioactive molecules such as enzymes and antibodies, into a broad range of cell types. The BioPORTER QuikEase kits contain individual tubes of the BioPORTER Reagent in a convenient, ready-to-use, single reaction format. Each tube contains sufficient material of the lyophilized BioPORTER Reagent to perform 1 reaction in a 6-well plate (or 35 mm dish), 4 reactions in a 24-well plate (or 16 mm wells), and 10 reactions in a 96-well plate.
Rechtliche Hinweise
BioPorter is a registered trademark of Gene Therapy Systems, Inc.
QuikEase is a trademark of Gene Therapy Systems, Inc.
Lagerklassenschlüssel
10 - Combustible liquids
WGK
WGK 3
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles
Guo JL and Lee VMY
The Journal of Biological Chemistry, 286(17), 15317-15331 (2011)
E. coli expression of a soluble, active single-chain antibody variable fragment containing a nuclear localization signal
Xiong H, et al.
Protein Expression and Purification, 66(2), 172-180 (2009)
Cancer vaccination drives Nanog-dependent evolution of tumor cells towards an immune-resistant and stem-like phenotype
Noh KH, et al.
Cancer Research, canres-ca3758 (2012)
Xianzhi Jiang et al.
Journal of virology, 85(5), 2325-2332 (2010-12-24)
The herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) is the only HSV-1 gene transcript abundantly expressed throughout latency. LAT null mutants have a significantly reduced reactivation phenotype. LAT's antiapoptosis activity is the major LAT factor involved in supporting
Jason C Sang et al.
Communications biology, 4(1), 613-613 (2021-05-23)
Aggregation of α-synuclein (α-syn) is closely linked to Parkinson's disease (PD) and the related synucleinopathies. Aggregates spread through the brain during the progression of PD, but the mechanism by which this occurs is still not known. One possibility is a
Active Filters
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.
